Literature DB >> 15016234

Molecular and biochemical analysis of the MODY syndromes.

W E Winter1.   

Abstract

Maturity onset diabetes of the young (MODY) is characterized by youth-onset diabetes that is inherited in an autosomal dominant (monogenic) pattern. Classic MODY accounts for less than 5% of cases of childhood diabetes in Caucasians, presents prior to age 25 years, is nonketotic, and may not require insulin treatment. A variant form of MODY that lacks a clearly defined genetic basis occurs in African Americans [atypical diabetes mellitus (ADM)] clinically presents more acutely and is initially insulin requiring. To date, five molecular causes of classic MODY have been identified: hepatocyte nuclear factor-4 alpha (HNF-4 alpha; MODY1), glucokinase (MODY2), hepatocyte nuclear factor-1 alpha (HNF-1 alpha; MODY3), insulin promoter factor-1 (IPF-1, MODY4), and hepatocyte nuclear factor-1 beta (HNF-1 beta; MODY5). MODY is studied as a model of beta cell hypofunction and modest insulinopenia. Clinical recognition of ADM is important for patient management to avoid confusion with type 1 diabetes mellitus.

Entities:  

Year:  2000        PMID: 15016234     DOI: 10.1034/j.1399-5448.2000.010206.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  10 in total

Review 1.  DNA methylation and its role in the pathogenesis of diabetes.

Authors:  Amita Bansal; Sara E Pinney
Journal:  Pediatr Diabetes       Date:  2017-05       Impact factor: 4.866

Review 2.  Diabetes in African Americans.

Authors:  M C Marshall
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

3.  Diabetes in a child on growth hormone therapy: Answers.

Authors:  Melanie Aldridge; Tony Huynh; Jose Prado; Steven J McTaggart
Journal:  Pediatr Nephrol       Date:  2017-03-27       Impact factor: 3.714

4.  The pancreatic islet β-cell-enriched transcription factor Pdx-1 regulates Slc30a8 gene transcription through an intronic enhancer.

Authors:  Lynley D Pound; Yan Hang; Suparna A Sarkar; Yingda Wang; Laurel A Milam; James K Oeser; Richard L Printz; Catherine E Lee; Roland Stein; John C Hutton; Richard M O'Brien
Journal:  Biochem J       Date:  2011-01-01       Impact factor: 3.857

5.  Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy.

Authors:  Tennille S Leak; Carl D Langefeld; Keith L Keene; Carla J Gallagher; Lingyi Lu; Josyf C Mychaleckyj; Stephen S Rich; Barry I Freedman; Donald W Bowden; Michèle M Sale
Journal:  BMC Med Genet       Date:  2010-02-08       Impact factor: 2.103

6.  Upstream stimulatory factor (USF) and neurogenic differentiation/beta-cell E box transactivator 2 (NeuroD/BETA2) contribute to islet-specific glucose-6-phosphatase catalytic-subunit-related protein (IGRP) gene expression.

Authors:  Cyrus C Martin; Christina A Svitek; James K Oeser; Eva Henderson; Roland Stein; Richard M O'Brien
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

7.  Susceptibility of glucokinase-MODY mutants to inactivation by oxidative stress in pancreatic β-cells.

Authors:  Kirsty S Cullen; Franz M Matschinsky; Loranne Agius; Catherine Arden
Journal:  Diabetes       Date:  2011-10-25       Impact factor: 9.461

8.  A Novel Mutation of the Glucokinase Gene in Maturity-onset Diabetes of the Young Type 2 (MODY2).

Authors:  Wakako Jo; Kenji Fujieda; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2010-05-22

9.  A Case of Novel Mutation of HNF1B in Maturity-onset Diabetes of the Young Type 5 (MODY5).

Authors:  Wakako Jo; Hitomi Sano; Akira Sudo; Yukiko Matsunami; Nobuaki Kawamura; Toshihiro Tajima
Journal:  Clin Pediatr Endocrinol       Date:  2012-07-25

10.  Diabetes in young: Beyond type 1.

Authors:  Anju Virmani; Abhishek Kulkarni
Journal:  Indian J Endocrinol Metab       Date:  2012-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.